Země: Austrálie
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
alendronate sodium, Quantity: 91.37 mg (Equivalent: alendronic acid, Qty 70 mg)
Pharmbio Pty Ltd
alendronate sodium
Tablet, effervescent
Excipient Ingredients: monosodium dihydrogen citrate; citric acid; sodium bicarbonate; sodium carbonate; acesulfame potassium; sucralose; Flavour
Oral
4, 1, 2
(S4) Prescription Only Medicine
Steovess is indicated for the treatment of osteoporosis. Prior to treatment, osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by the presence of osteoporotic fracture
Visual Identification: White to off-white round, flat tablet with bevelled edges; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
2012-06-18